Asymptomatic “breakthrough” thrombosis and anticoagulant “failure”: Keep calm and carry on

Research output: Contribution to journalArticlepeer-review

Abstract

Despite therapeutic anticoagulation, patients with venous thromboembolism (VTE) not uncommonly present with findings of progressive thrombosis, sometimes within the first several weeks of treatment. While the prevailing strategy in these scenarios is to assume the current anticoagulant is ineffective and to switch to a different drug class, this practice may be unnecessary. Numerous trials of heparins and vitamin K antagonists for VTE have demonstrated that asymptomatic thrombus propagation despite therapeutic anticoagulation is common. While similar, serial imaging studies after initial VTE have not been replicated in trials of the direct oral anticoagulants, we reason that asymptomatic thrombus propagation detected within the first month of VTE diagnosis can be managed with continuation of the current anticoagulant strategy and close follow-up for worsening or recurrent symptoms.

Original languageEnglish (US)
Pages (from-to)498-502
Number of pages5
JournalResearch and Practice in Thrombosis and Haemostasis
Volume3
Issue number3
DOIs
StatePublished - Jul 2019

Keywords

  • anticoagulant
  • heparin
  • postthrombotic syndrome
  • thrombosis
  • venous thromboembolism

ASJC Scopus subject areas

  • Hematology

Fingerprint

Dive into the research topics of 'Asymptomatic “breakthrough” thrombosis and anticoagulant “failure”: Keep calm and carry on'. Together they form a unique fingerprint.

Cite this